State of the Art Answers to 500 Mold Questions EBOOK
Sickened by moldy buildings? Need facts and answers fast? Here is your guide: State of the Art Answers for 500 Mold Questions. Thorough and reliable, “500 Answers” is as current as one can find on a subject where bad information abounds. But, as far as sick people go, what I write here will need to be updated when we finally have genomic information. The world of diagnosis and treatment of chronic inflammatory response syndromes (CIRS) acquired following exposure to the interior environment of water-damaged buildings (WDB) now relies on proteomics and differential diagnosis. Call it “mold illness,” if you will. You need to know the latest and best information about human health effects caused by wet, moldy buildings and the importance of understanding human health effects before remediation begins. The time to share what really is going on in sickened people has been with us for nearly 20 years, yet so much just plain wrong information is out there. Our knowledge has reached new levels as therapies like use of vasoactive intestinal polypeptide (VIP) show us where we need to go to reduce reactivity and stop the systemic inflammation of CIRS-WDB.
500 Answers includes new discoveries like the information we obtain from NeuroQuant that shows that the inflammation of CIRS causes the development of a distinctive fingerprint of injury to the central nervous system found just in CIRS-WDB patients. Better still, use of NeuroQuant shows us that the ability to correct the inflammatory response will in turn show correction of localized areas of grey matter atrophy in the brain. This result of treatment is unheard of in the world of brain injury. If you want to confirm that your executive cognitive functioning is due to exposure to WDB, do a NeuroQuant as part of the full work up.
If you simply want to know what to do to obtain a diagnosis that is accurate and begin therapies that work, 500 Answers is a must read. If you need solid information on how to go about testing your home, school and workplace to see if those buildings could be making you sick, 500 Answers is for you as well.
If you don’t have any experience with human health effects cause by wet buildings, and you are understandably overwhelmed by the fuzzy “science” on the Internet, 500 Answers is your portal to a sharp vision of what is wrong and what needs to be done.
500 Answers has a complete Table of Contents, a roster of the many acronyms used and an index that will help you find out quickly what you want to know. The information in 500 Answers is correct but when we add genomics, the jargon terms and new information is going to require a steep learning curve. We welcome you to learn what you need to know now. We will help you with the new understanding too when the time comes.
Featured Resources for Shoemaker Protocol
Better than Resolutions
Every year when the New Year rolls around, people begin to make goals and resolutions to be more health-focused, especially after a busy, festive holiday season.
Common Questions & Answers about Cholestyramine (and why it’s the most effective option out there).
Cholestyramine (CSM) is an FDA-approved medication used in an initial stage of The Shoemaker Protocol because it has a unique affinity for binding with biotoxins and effectively eliminating them from the body.
No luck finding a Shoemaker Certified Practitioner? Here are some solutions:
The top inquiries to our site continue to be, ‘”Is there a Shoemaker Certified Practitioner near me? And, “Is there one who also takes my insurance?” While we don’t have practitioners in every region as of yet, many certified practitioners are set...
GENIE (Genomic Expression: Inflammation Explained) Now Available!
Yes, the test is now here. After ten years in concept and three years in development and validation, the application of transcriptomics to confirm hypometabolism (see below) is available. Based on the work of James Ryan, PhD
Online Proficiency Partners Course
Join a life-changing team helping patients with CIRS recover and thrive.